Scion Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-300,000
Closed -$21.9M 4
2022
Q1
$21.9M Hold
300,000
10.88% 2
2021
Q4
$18.7M Buy
+300,000
New +$17.6M 25.12% 1

Other funds holding BMY

Scion Asset Management's BMY Position: Q2 2022 in Review

Scion Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2022, closing a stake of 300,000 shares — an estimated $21.9M sold.

Scion Asset Management first reported a position in BMY in Q4 2021 and held it in 2 quarters. The position peaked at $21.9M in Q1 2022. 2,537 funds tracked by Wall St. Rank hold BMY as of Q2 2022.

  • Scion Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2022 after selling out during the quarter.
  • Scion Asset Management sold 300,000 Bristol-Myers Squibb shares in Q2 2022, an estimated $21.9M.
  • Scion Asset Management first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 2 quarters.
  • Scion Asset Management's Bristol-Myers Squibb position peaked at $21.9M in Q1 2022.
  • 2,537 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.

Based on Scion Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.